Author:
Zaki Syed Ahmed,Krishnamurthy Mohan B.,Malhotra Atul
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Testoni D, Hornik CP, Neely ML, Yang Q, McMahon AW, Clark RH, Smith PB, Best Pharmaceuticals for Children Act-Pediatrics Trial Network Administrative Core Committee. Safety of octreotide in hospitalized infants. Early Hum Dev. 2015;91:387–92.
2. Shah D, Sinn JK. Octreotide as a therapeutic option for congenital idiopathic chylothorax: a case series. Acta Paediatr. 2012;101:e151–5.
3. US Food and Drug Administration. Sandostatin (octreotide acetate) injection.
http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019667s061lbl.pdf
. Accessed 8 Aug 2017.
4. Das A, Shah PS. Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst Rev. 2010;9:CD006388.
5. Aljazairi AS, Bhuiyan TA, Alwadai AH, Almehizia RA. Octreotide use in post-cardiac surgery chylothorax: a 12 year perspective. Asian Cardiovasc Thorac Ann. 2017;25:6–12.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献